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Abstract Heterotrimeric G proteins are recognized as versatile 
switches linking cell surface receptors to cellular effectors. 
Beside their location at the plasma membrane G proteins are 
found on intracellular membranes. Studies with modulators of G 
protein activity suggest hat G proteins associated with organelle 
membranes are involved in various steps of secretion and 
vesicular function. In contrast to hormonal responses involving 
G proteins little is currently known about possible receptors or 
activators and effectors interacting with intracellular G proteins. 
This short review focuses on recent developments elucidating the 
role of organelle-associated G proteins. 
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1. Heterotrimerie G proteins are switches for hormonal signal 
transduction 
Guanine nucleotide binding proteins are members of a 
superfamily of GTPase enzymes (EC 3.6.1.-) which function 
as versatile cyclic molecular switches [1,2]. They are subdi- 
vided into monomeric GTPases and heterotrimeric G proteins 
(or G proteins). Monomeric GTPases, currently subdivided 
into five subfamilies, namely Ras, Rab, ARF, Ran and 
Rho, are found in the cytoplasm and membrane associated, 
where they are involved in diverse cellular events such as 
transmission of hormonal signals, modulation of cell growth 
and development, protein transport, cytoskeleton architecture, 
vesicular functions and exocytosis. Heterotrimeric G proteins 
are best known as membrane-associated transducers mediat- 
ing exterior hormonal and neurotransmitter signals to the cell 
interior [3,4]. G proteins are composed of three different sub- 
units termed ~, 1~ and T, with molecular masses of approxi- 
mately 39-52 kDa, 35-39 kDa and 6-8 kDa, respectively. 
They are classified according to the nature of their Gc~ subunit 
into four families: G~ (includes four splice variants of (38, 
GxLs and Golf), Gi (includes Gil, Gi2, Gi2L, Gi3, Gol, Go2, 
Ggust, Gt .... Gz), Gq (includes Gq, Gll, G14, G15, G16), and 
G12 (includes G12 and G13) [5]. Currently, 23 different a sub- 
units including several splice variants of Gs, Gi and Go, 6 GI3 
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(G~I 6) and 11 G 7 (Co'1_5,7_12) subunits are known. Recently, 
the crystal structures of two heterotrimeric G proteins were 
resolved [6]. 
A hallmark of G protein-dependent signal transduction is
the sequential and reversible assembly of a protein complex 
composed of three elements, i.e. a heptahelical (or serpentine 
transmembrane spanning) receptor, a transducer (i.e. hetero- 
trimeric G protein) and an effector (i.e. enzyme, ion channel 
or transporter) [7-9]. Activation of the G protein is initiated 
by its interaction with distinct cytoplasmic segments of a li- 
gand-activated heptahelical receptor. As the result GDP 
bound to the Ga  subunit is released (Fig. 1) [10]. Most likely, 
GDP release is the rate-limiting step of the G protein activa- 
tion reaction, followed by high affinity binding of cytosolic 
GTP. Mg 2+ is very tightly associated with GTP and Gc~ in 
this complex and is required for activation of the Gc¢ subunit 
and for the subsequent hydrolytic activity. Upon G protein 
activation, the Ga-GTP subunit dissociates from the GI3T 
complex. Both the activated Ga-GTP subunit and the Gl~y 
complex modulate effector proteins until hydrolysis of the 
GTP bound to the Gcx subunit terminates ignaling (by an 
intrinsic GTPase activity). The GTPase activity of the Ga 
subunit is modulated by certain effectors (e.g. cGMP-depen- 
dent phosphodiesterase, phospholipase C-13, L-type calcium 
channel) which, thereby, function as GAPs (in analogy to 
the GTPase-activating proteins of the monomeric GTPases). 
Following GTP hydrolysis, the inactive GDP-bound G~ sub- 
unit dissociates from the effector and reassociates with the 
GI33, complex to form a Gc~y heterotrimer. This inactivated 
heterotrimer then becomes available for subsequent activation 
cycles. The spontaneous and receptor-stimulated GDP/GTP 
exchange reactions vary among different G proteins: Gi pro- 
teins are fast nucleotide xchangers, G~, Gz and G proteins of 
the Gq subfamily show smaller rate constants, and for G12 
and G13 very low guanine nucleotide exchange rates have 
been reported [11,12]. 
2. Approaches to study effects of intracellular G proteins 
Apart from their location at the plasma membrane, G pro- 
teins are also detected in the cytoplasm and found attached to 
various intracellular membranes belonging to the Golgi com- 
plex, endoplasmic reticulum, endosomes and secretory vesicles 
[13]. In addition, two recently identified members of G pro- 
teins, i.e. GXLS and Gi2L, were reported to be specifically as- 
sociated with the Golgi apparatus [14,15]. However, little is 
known about the functions of organelle-associated G proteins 
[16,17]. In addition, components interacting upstream and 
downstream with these G proteins have not been identified 
so far. 
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As physiological activators are not available, various ex- 
perimental tools are widely used to elucidate functions of G 
proteins on intracellular membranes. Stable guanine nucleo- 
tides such as GTPyS or GppNHp shift the equilibrium of 
heterotrimeric G proteins towards the dissociated active forms 
of Get and G~?. Careful interpretation of results obtained 
with GTP3,S is required, since kinases do utilize nucleoside 
thiophosphates. Activation of heterotrimeric G proteins but 
not monomeric GTPases is accomplished by incubation with 
AIF4 [18]. However, A1F4- also affects various other en- 
zymes. Additionally, high concentrations of fluoride may 
change the free concentrations of Ca ~+ and Mg 2+ thus gen- 
erating unspecific effects. 
Covalent modifications of Gc~ subunits catalyzed by cholera 
toxin (CT) and pertussis toxin (PT) represent another ap- 
proach to study functions of some G proteins [19]. CT modi- 
fies an arginine residue located in the nucleotide binding re- 
gion of the Get subunit (see below). Gets proteins are modified 
by CT in a receptor-ligand-independent ma ner whereas Gett 
(transducin) and Geti/o are modified in a receptor-ligand-de- 
pendent manner. The CT-catalyzed ADP-ribosylation 
abolishes the endogenous GTPase activity, resulting in con- 
tinuous activation of the Get subunit. It has to be kept in 
mind that CT ADP-ribosylates many other proteins besides 
G proteins [20]. In contrast o CT, PT catalyzes the transfer of 
an ADP moiety from NAD + to a cysteine residue of the et 
subunit of Gi/G o and Gt. Since the modified cysteine is lo- 
cated four residues upstream of the carboxy-terminus, PT- 
catalyzed ADP-ribosylation prevents interaction of the recep- 
tor with the G protein, thus resulting in a functional receptor- 
G protein uncoupling. Nevertheless, PT-modified G proteins 
are still exchanging GDP for GTP, thereby switching them 
into their active conformation. The activated ADP-ribosylated 
G proteins do interact with effectors though the time required 
to observe maximal effect by GTP,/S can be markedly in- 
creased [21]. This alteration in the kinetics, i.e. a time-depen- 
dent inhibition of the G protein-effector interaction, is 
exploited to look for G protein-dependent effects on endo- 
membranes. 
Cationic amphiphilic peptides like the wasp venom tetrade- 
capeptide mastoparan stimulate preferentially G~/o proteins in 
a PT-sensitive manner. These peptides probably resemble ct- 
helical cytosolic domains of G protein-coupled receptors (see 
above) [22]. Consequently, peptides derived from receptor do- 
mains suggested to couple to G proteins are also used. How- 
ever, these tools exert limited specificity since mastoparan 
among other G protein-activating peptides hows pleiotropic 
effects on various proteins ([23] and references cited therein). 
An additional disadvantage of mastoparan-like p ptides ap- 
pears to be their amphiphilic haracter which disturbs the 
lipid bilayer of biomembranes at concentrations similar to 
those used to stimulate G proteins [24]. Furthermore, masto- 
paran abolishes the membrane potential of isolated secretory 
granules (G. Ahnert-Hilger and R. Jahn, unpublished). Other 
approaches exploring the role of G proteins involve specific 
antibodies and purified G proteins as well as overexpression 
of wild type and constitutively activated isoforms and intro- 
duction of antisense oligonucleotides into target cells [4,25,26]. 
3. Functions of G proteins on organelle membranes 
Based on largely indirect evidence (see above), G proteins 












Fig. 1. Activation/inactivation cycle of G proteins. ~, [~ and y repre- 
sent the Ga, G~I and Cr,/subunits of the G protein. G proteins are 
activated by ligand-stimulated receptors or activators such as masto- 
paran, mastoparan-like p ptides or other cationic amphiphilic om- 
pounds. PT-catalyzed ADP-ribosylation functionally uncouples the 
G protein from the receptor whereas CT-mediated modification of 
Get abolishes the GTPase activity of the G protein. For details ee 
text. 
have been suggested to regulate various membrane trafficking 
processes including exocytotic membrane fusion. For detailed 
information the reader is referred to recent reviews 
[16,17,27,28]. 
Cellular products destined for export are packaged in secre- 
tory vesicles which are transported along a constitutive or a 
regulated pathway [29]. Several steps of constitutive secretion 
appear to be controlled by heterotrimeric G proteins. Data 
suggest that G proteins regulate membrane trafficking by con- 
trolling coat assembly [30,31]. Trafficking of proteoglycans 
through the Golgi apparatus is tonically suppressed by Geti3 
[32]. Furthermore, in polarized cells the sorting of newly 
synthesized proteins to the apical surface appears to be under 
the control of a CT-sensitive protein, probably Gs, whereas 
transport directed to the basolateral plasma membrane is 
modulated by PT-sensitive Gi proteins [33]. Regulated secre- 
tion of neurons and neuroendocrine c lls is mediated by two 
types of secretory vesicles, large dense core vesicles (LDCV) 
and small synaptic vesicles (SSV). In the rat pheochromocy- 
toma cell line PC-12 the formation of LDCV is inhibited by 
PT-sensitive Gi/o proteins and stimulated by the CT-sensitive 
Gs [34]. 
PT-sensitive G proteins are predicted to be involved in final 
steps of exocytosis based on experiments employing poorly 
hydrolyzable GTP analogues, A1F4- and mastoparan 
[35,36]. Exocytotic membrane fusion is based primarily on a 
sequential interaction between proteins of the cytoplasm, the 
secretory vesicles, and the plasma membrane. Several steps 
may be distinguished including an ATP-dependent priming 





cell surface receptor effector 
NNN nrn  
plasma membrane ~: 
cytoplasm (d) ? ~ 
(b)?  ,, X 
v , "  
, @ (a)?, -" 







Fig. 2. Speculative model of the signal transduction elements involved in activation of organelle-associated G proteins. G0tl~ Y heterotrimers are 
associated with plasma or organelle membranes. Seven-transmembrane cell surface receptors activate G proteins following ligand binding which 
in turn allows regulation of cellular effectors through activated issociated G~-GTP and GI~T subunits. Note that G protein-regulated effectors 
such as enzymes or ion channels can be localized transmembranous (e.g. ion channels, adenylyl cyclases), membrane associated (e.g. phospholi- 
pases CI3) or cytosolic (e.g. phosphoinositide 3-kinase 7). Organelle-associated G proteins may be stimulated by an yet unkown cytosolic activa- 
tor (a). Previously, GAP 43 was suggested to be such an activator. In addition, activation of the organelle-associated G protein may be under 
the control of effectors regulated by plasma membrane-associated G proteins (b) or components of other signal transduction pathways (c). The- 
oretically, following membrane fusion of secretory vesicles with the plasma membrane, cell surface receptors may couple directly to endomem- 
brane G proteins (d). Intracellular G proteins may also be stimulated by a seven-transmembrane ec ptor spanning the organelle membrane ( ). 
In this case, the receptor agonist has to bind from the luminal side to the receptor, thereby initiating transmembrane signaling. Organelle-asso- 
ciated G proteins may activate various effectors. One such effector may be the monoamine transporter on large dense core vesicles of chromaf- 
fin cells. For details see text. 
step and a Ca2+-dependent step leading to final fusion [37-39]. 
An ATP-dependent priming step is suggested to be under the 
inhibitory control of Go proteins located on chromaffin gran- 
ules [40,41], whereas Gi3 associated with the plasma mem- 
brane stimulates an ATP-independent Ca2+-elicited step dur- 
ing final exocytotic membrane fusion [42]. Whether the 
inhibitory effects of Go on exocytosis are mediated by vesi- 
cle-associated G proteins or by Ga  subunits activated by a 
receptor interaction at the plasma membrane is currently un- 
resolved. Since exocytosis always requires the interaction be- 
tween vesicle and plasma membrane a clear-cut distinction of 
the origin of G proteins involved is difficult to obtain. A direct 
control of exocytosis by receptor-mediated activation of G 
proteins was recently described for ~2-adrenergic receptors 
in an insulin-secreting cell line [42]. 
The observation that GI3 (GI31 and G132) and CO' subunits 
(G~2 and/or G73) are colocalized with Ga  subunits on intra- 
cellular membranes including those of two types of secretory 
vesicles suggests pecific functions of organelle-associated G 
proteins [43,44]. Both types of secretory vesicles in neurons 
and neuroendocrine c lls contain heterotrimeric forms of G 
proteins but differ in their pattern of Ga  subunits. SSV con- 
tain four different PT substrates, i.e. G~ol, G(~o2, G~il and 
G(2i2. SSV are not regarded as a homogeneous vesicle popula- 
tion because they differ in their ability to accumulate various 
transmitters uch as y-aminobutyric acid (GABA), glycine, 
glutamate, and monoamines [45]. Conversely, LDCV from 
bovine adrenal medulla represent a more homogeneous vesicle 
population. In addition, LDCV from bovine adrenal medulla 
exhibit only one PT-sensitive G protein, most likely GCCo2, in 
large quantities. 
The latter observation suggests a possible role of this par- 
ticular G protein for chromaffin granule functions. Employing 
various experimental approaches, evidence has accumulated 
indicating that a PT-sensitive G protein inhibits the ATP-de- 
pendent and reserpine-sensitive catecholamine uptake into 
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LDCV of streptolysin O (SLO)-permeabilized PC-12 cells 
[46]. In a more direct way, purified bovine brain Gc~ subunits 
were introduced into SLO-permeabilized PC-12 cells. With 
this approach GTP,/S-activated Gao2 but not GDP-bound 
Gao2 has been identified as a specific inhibitor of neurotrans- 
mitter uptake. Other PT-sensitive Ga  subunits and a mixture 
of bovine brain G[3~/complexes were without effect. Vesicular 
acidification is not inhibited by G proteins, suggesting that the 
vesicular monoamine transporter ather than the vacuolar 
ATPase is affected. 
Go proteins are the most abundant proteins in neuronal and 
neuroendocrine cells comprising about 1% of total brain 
membrane proteins [47]. Conversely, our knowledge about 
specific functions of Go is extremely scarce. In mammalian 
cells both Go isoforms mediate receptor-induced inhibition 
of voltage-gated calcium channels. This has been initially 
identified by infusion of purified Gao subunits into PT-pre- 
treated cells and stimulation of Gi/Go-coupled receptors [48]. 
More recently, intranuclear microinjection of specific anti- 
sense oligonucleotides in combination with the patch clamp 
technique allowed identification of specific GoC~13 Y heterotri- 
mers but not Gi proteins being involved in signal transduction 
pathways regulating voltage-activated calcium channels [26]. 
Lately, results from two groups imply that the G~y complex 
of Go may be the active moiety interacting with calcium chan- 
nels [49,50]. This finding raises the question why receptor-ac- 
tivated G~'/complexes should only be released from Go but 
not from Gi since both G proteins couple to receptors mod- 
ulating calcium channel activity. One possible xplanation for 
the observed specificity of heterotrimer subunit composition is
a compartmentalization of the signal transduction elements in 
the plasma membrane of intact cells [26]. Nevertheless, the 
G~o subunit is currently without a specific effector-regulating 
function, though results obtained from modulating ene ex- 
pression of the G~o gene in the roundworm Caenorhabditis 
elegans underline an important role of this G protein in var- 
ious neuronal functions [51,52]. 
A large body of evidence suggests that heterotrimeric G 
proteins regulate various endocytotic trafficking processes. 
This includes clathrin-coated vesicle-mediated endocytosis 
[53] and endocytosis through caveolae [54], transcytosis [55] 
as well as endosome membrane fusion [43,56]. 
4. What are the upstream signaling partners of organelle-asso- 
ciated G proteins? 
The nature of putative regulators of organelle-associated G 
proteins is highly speculative at the moment (Fig. 2). In par- 
ticular, it can only be hypothesized which factors are involved 
in the upstream regulation of Goz located on chromaffin gran- 
ules (see above). Principally, organelle-associated G proteins 
may be regulated by cytosolic proteins or by membranous 
factors analogous to heptahelical cell surface receptors. It is 
suggested that the cytosolic, depalmitoylated phosphoprotein 
GAP 43 may play a role by stimulating vesicle-associated Go 
in chromaffin cells [57]. The physiological relevance of intra- 
cellular G protein activation by GAP 43 requires additional 
investigation. Fully processed GAP 43 is located exclusively 
on the intracellular side of the plasma membrane of neurons 
[58]. It is expressed at high levels in neuronal growth cones 
during development and during axonal regeneration where it 
activates Go which is also enriched in these neuronal compart- 
ments [59,60]. Alternatively, organelle-associated receptors 
spanning the lipid bilayer may exist which couple to hetero- 
trimeric G proteins. In this context, the Lys-Asp-Glu-Leu 
(KDEL) receptor may be of interest since this molecule is 
suggested to exhibit a topology of seven transmembrane do- 
mains being localized on the trans side of the Golgi stack [61]. 
In addition, receptors other than those with seven transmem- 
brane domains have been predicted to couple directly to het- 
erotrimeric G proteins. Among them is the single membrane 
spanning mannose-6-phosphate (M6P)/IGF II receptor which 
was demonstrated to couple directly to Gi2 proteins [62]. 
However, detailed molecular analysis revealed that the M6P/ 
IGF II receptor is not directly linked to G proteins [63] 
though IGF II is able to stimulate calcium influx into cells 
in a PT-sensitive fashion [64,65]. The latter effect may be due 
to stimulation of other receptors or alternatively due to indir- 
ect coupling to G proteins by an as yet unknown molecular 
mechanism. 
Although the signaling molecules upstream of organelle-as- 
sociated G proteins have not yet been identified, one may 
speculate about the triggering mechanisms leading to activa- 
tion of these G proteins. Transmembrane signaling during 
biogenesis of secretory granules may be achieved by aggrega- 
tion of secretory proteins in the trans-Golgi network as sug- 
gested for chromogranin B in PC-12 cells [66]. In this case 
luminal aggregation may activate G proteins on the cytosolic 
side of the Golgi membrane thereby promoting the budding of 
secretory granules [34]. It may also be speculated that Go2 
inhibits vesicular monoamine transporters in response to a 
sensor in the vesicular lumen that controls neurotransmitter 
loading. Alternatively, a switch of the vesicular pH or ionic 
environment may lead to activation of G~o2 via a putative 
receptor egulating monoamine transporter activity during fi- 
nal exocytosis or endocytotic membrane retrieval. 
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